GLEN ALLEN, Va., Oct. 09, 2025 (GLOBE NEWSWIRE) -- Adial Pharmaceuticals, Inc. (NASDAQ: ADIL) (“Adial” or the “Company”), a clinical-stage biopharmaceutical company focused on developing therapies for ...
Partnership has successfully completed analytical validation of a cheek swab collection solution for testing and identifying patients with the genotypes important for AD04 development GLEN ALLEN, Va., ...
(MENAFN- GlobeNewsWire - Nasdaq) Partnership has successfully completed analytical validation of a cheek swab collection solution for testing and identifying patients with the genotypes important for ...
GLEN ALLEN, Va., Oct. 09, 2025 (GLOBE NEWSWIRE) -- Adial Pharmaceuticals, Inc. (NASDAQ: ADIL) ("Adial" or the "Company"), a clinical-stage biopharmaceutical company focused on developing therapies for ...
Genomind’s pharmacogenetic testing, which is transforming the landscape of precision medicine, uses a simple cheek swab to assess genes that influence drug metabolism, tolerability, and efficacy. The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback